(Press-News.org) (MEMPHIS, Tenn. – May 04, 2023) Despite the astounding advances made in understanding the biologic underpinnings of cancer, many cancers are missing obvious genetic drivers. When scientists can’t pinpoint the factors that drive cancer, treating it can be much more difficult. Scientists at St. Jude Children’s Research Hospital hope to solve that problem with an updated way to analyze multi-omic (primarily transcriptomics and proteomics) data. The researchers created a next-generation computational tool to gain new insights from biological data and find hidden druggable targets. The tool’s capabilities were published in Nature Communications today.
The updated application, NetBID2, successfully uncovers difficult-to-identify proteins that drive biological processes (such as rapid cell growth) contributing to cancer. These hidden drivers present new therapeutic opportunities, either because existing drugs can already target them or because they might inspire drug developers to make new therapeutics.
“We made it easier to find hidden drivers,” said corresponding author Jiyang Yu, Ph.D., St. Jude Department of Computational Biology. “Finding hidden drivers is important because many of these are potentially druggable targets. NetBID2 can find these drivers and potentially move them quickly into clinical trials. We may be able to re-purpose an already FDA-approved drug that targets an identified hidden driver to a completely different patient population that may benefit.”
A network approach to finding hidden drivers
Large sets of RNA sequencing data from specific cells or cancer types can contain valuable information necessary to find hidden drivers of disease; however, standard analysis tools struggle to find them. NetBID2 is a sequel to the original tool developed by Yu in 2018. He specifically designed these tools to find hidden drivers by squeezing out more from “big data.”
“NetBID2 enables us to maximize the data we have,” said Yu, “particularly RNA sequencing data. It goes beyond the traditional mutation or differential gene expression data to expose hidden events and information that may be functionally important.”
Hidden drivers cannot be discovered by conventional genomics or sequencing approaches because their activity depends on post-translational modifications and other mechanisms that are invisible to traditional sequencing but affect the expression of other genes.
Therefore, NetBID2 takes RNA sequencing data, then generates a gene-gene interactome. This interactome tracks the relationships between driver candidates and their downstream effector genes to determine which signaling proteins are most central to the key relationships that fuel disease. These “central hubs” directing the network are the hidden drivers.
“NetBID2 looks for a hidden driver like the FBI would look for a crime boss,” Yu said. “If you look at the suspect, there’s no direct evidence to connect them with any crime. The way to capture them is first to build a network of associates. We do the same when we build the biological network by collecting a lot of data on its members and their relationships. Then we look for the boss’s first neighbors in the network when we look at a hidden driver’s activity. That’s the only way to capture the boss — by inference from their activities — otherwise, there is no way to identify them. We find these hidden drivers’ guilt by association.”
As proof of the tool’s capabilities, the St. Jude group showed it could find biologically meaningful hidden drivers in three unrelated samples. Using NetBID2, the team found unappreciated roles for MYC in adult lung cancer and for NOTCH1 in difficult-to-treat pediatric leukemia that standard differential expression analysis at the mRNA or protein levels hadn’t uncovered, despite the genes’ having been previously linked to cancer. They also found an unappreciated role for Gabpa in normal immune cell function. The gene’s importance was context-specific in each case, highlighting the need for targeted analyses.
The software’s other capabilities, such as new visualization tools, are meant to facilitate further analysis and discovery of hidden drivers from complex networks of RNA-seq and, in some cases, proteomics data.
NetBID2 is freely available on a GitHub repository. The St. Jude Cloud, which includes a NetBID2 app and data from many multi-omics projects, is also freely available for other scientists to use for further discovery of hidden drivers of basic biology and disease.
Authors and funding
The study’s first author is Xinran Dong, formerly of St. Jude. The other authors are Liang Ding, Andrew Thrasher, Xinge Wang (formerly), Jingjing Liu, Qingfei Pan, Jordan Rash, Yogesh Dhungana, Xu Yang, Isabel Risch (formerly), Yuxin Li (formerly), Lei Yan, Michael Rusch, Clay McLeod, Koon-Kiu Yan, Junmin Peng, Hongbo Chi and Jinghui Zhang, all of St. Jude.
The study was supported by grants from the National Institutes of Health (R01GM134382, U01CA264610 and P30CA021765-403 41S3) and ALSAC, the fundraising and awareness organization of St. Jude.
St. Jude Media Relations Contacts
Chelsea Bryant
Cell: (256) 244-2048
Desk: (901) 595-0564
chelsea.bryant@stjude.org
media@stjude.org
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is leading the way the world understands, treats and cures childhood cancer, sickle cell disease and other life-threatening disorders. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20% to 80% since the hospital opened more than 60 years ago. St. Jude shares the breakthroughs it makes to help doctors and researchers at local hospitals and cancer centers around the world improve the quality of treatment and care for even more children. To learn more, visit stjude.org, read St. Jude Progress blog, and follow St. Jude on social media at @stjuderesearch.
END
St. Jude tool gets more out of multi-omics data
2023-05-04
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Alternative fuel for string-shaped motors in cells
2023-05-04
Cells have a fascinating feature to neatly organize their interior by using tiny protein machines called molecular motors that generate directed movements. Most of them use a common type of fuel, a kind of chemical energy, called ATP to operate. Now researchers from the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG), the Cluster of Excellence Physics of Life (PoL) and the Biotechnology Center (BIOTEC) of the TU Dresden in Dresden, Germany, and the National Centre for Biological Sciences (NCBS) in Bangalore, India, discovered a novel molecular system that uses an alternative chemical energy and employs a novel mechanism ...
How seaweed has been misleading scientists about reef health
2023-05-04
For decades, scientists have looked to seaweed as an indicator of the health of coral reefs lying underneath.
But what if the seaweed was misleading them?
New UBC research reveals it was, and scientists need new ways to determine whether human activity is harming a particular reef.
"This is especially critical today, given that reefs globally are threatened by climate-driven stressors,” said Dr. Sara Cannon, a postdoctoral fellow at the UBC Institute for the Oceans and Fisheries and the study's lead author.
Local species ...
CityU researchers develop an additive to efficiently improve the efficiency and stability of perovskite solar cells
2023-05-04
Perovskite solar cells (PVSCs) are a promising alternative to traditional silicon-based solar cells because of their high power-conversion efficiency and low cost. However, one of the major challenges in their development has been achieving long-term stability. Recently, a research team from City University of Hong Kong (CityU) made a breakthrough by developing an innovative multifunctional and non-volatile additive which can improve the efficiency and stability of perovskite solar cells by modulating perovskite film growth. This simple and effective strategy has great potential for facilitating the commercialisation of PVSCs.
“This type of multifunctional ...
Research reveals longstanding cultural continuity at oldest occupied site in West Africa
2023-05-04
Evidence from West Africa about human evolution remains scarce, but recent research has indicated unique patterns of cultural change in comparison to other regions of the continent. A new article in the journal Nature Ecology and Evolution adds to our understanding with a study of the oldest directly dated archaeological site in West Africa. The site shows technological continuity spanning roughly 140,000 years and offers insights into the ecological stability of the region.
Our species emerged in Africa around 300 thousand years ago and ...
A simple antibacterial treatment solves a severe skin problem caused by radiation therapy
2023-05-04
BRONX, NY—May 4, 2023—Acute radiation dermatitis (ARD)—characterized by red, sore, itchy or peeling skin—affects up to 95% of people undergoing radiation treatment for cancer. Severe cases can cause significant swelling and painful skin ulcers that can severely impair quality of life, yet little is known about why this condition occurs and no standardized treatments for preventing severe ARD have been widely adapted.
Researchers at Montefiore Einstein Cancer Center (MECC) have found that many cases of ARD involve a common skin bacterium and that a simple, low-cost treatment ...
Fred Hutch study highlights racial disparities in ovarian cancer risk for women
2023-05-04
SEATTLE, WA — May 4, 2023 — A new Fred Hutchinson Cancer Center study in the journal Obstetrics & Gynecology investigated how endometriosis, uterine leiomyomas (also known as fibroids) and a common intervention for these conditions—hysterectomy—changed ovarian cancer risk in Black and white women.
Scientists found fibroids were associated with an increased risk of ovarian cancer in both Black and white women, with hysterectomy modifying the risk of cancer in both groups. However, researchers also found that while Black and white women with endometriosis had a higher risk of ovarian cancer overall, hysterectomy only ...
Vanishing glaciers threaten alpine biodiversity
2023-05-04
Vanishing glaciers threaten alpine biodiversity
With glaciers melting at unprecedented rates due to climate change, invertebrates that live in the cold meltwater rivers of the European Alps will face widespread habitat loss, warn researchers.
Many of the species are likely to become restricted to cold habitats that will only persist higher in the mountains, and these areas are also likely to see pressures from the skiing and tourism industries or from the development of hydroelectric plants.
The research study – led jointly by the University of Leeds and ...
Neuropathic pain: The underlying mechanism and a potential therapeutic target are revealed in mice
2023-05-04
BIRMINGHAM, Ala. – Neuropathic pain — abnormal hypersensitivity to stimuli — is associated with impaired quality of life and is often poorly managed. Estimates suggest that 3 percent to 17 percent of adults suffer from neuropathic pain, including a quarter of people with diabetes and a third of people with HIV.
In a paper published in the journal Neuron, researchers report that a mechanism involving the enzyme Tiam1 in dorsal horn excitatory neurons of the spinal cord both initiates and maintains neuropathic pain. Moreover, they show that targeting spinal Tiam1 with anti-sense oligonucleotides injected ...
Breast cancer tumors disrupt the immune system remotely favoring their own growth
2023-05-04
Researchers at Baylor College of Medicine and collaborating institutions have identified a strategy cancerous tumors use to remotely disrupt the development of an immune response that could stop their growth.
Published in the journal Cell Stem Cell, the study shows in animal models that breast cancer tumors send molecular signals to the bone marrow, the birthplace of immune cells. The signals alter the natural environment of the bone marrow in such a way that it suppresses the response to fight back the tumor. Interestingly, ...
Young men at highest risk of schizophrenia linked with cannabis use disorder
2023-05-04
Young men with cannabis (marijuana) use disorder have an increased risk of developing schizophrenia, according to a study led by researchers at the Mental Health Services in the Capital Region of Denmark and the National Institute on Drug Abuse (NIDA) at the National Institutes of Health. The study, published in Psychological Medicine, analyzed detailed health records data spanning 5 decades and representing more than 6 million people in Denmark to estimate the fraction of schizophrenia cases that could be attributed ...